CVE-2022-26239

Description

The default privileges for the running service Normand License Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows unprivileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.

Category

5.5
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.03%
Third-Party Advisory pastebin.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance product
https://pastebin.com/1QEHrj01 third party advisory

Frequently Asked Questions

What is the severity of CVE-2022-26239?
CVE-2022-26239 has been scored as a medium severity vulnerability.
How to fix CVE-2022-26239?
To fix CVE-2022-26239, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-26239 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-26239 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.